Skip to content

Brief talking therapies on wards

Mindfulness-based crisis interventions (MBCI) for psychosis within acute inpatient psychiatric settings: a feasibility randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37625384
Enrollment
60
Registered
2015-08-19
Start date
2015-10-01
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health

Interventions

1. Control therapy - SAT, Social Activity Therapy (SAT) is a brief intervention (1-5 sessions) which involves helping the client to identify activities they enjoy, and carrying these out with the ther
2. Talking therapy - MBCI, Mindfulness-Based Crisis Interventions (MBCI) is a brief therapy (1-5 sessions) focussing on developing a shared understanding of what has brought the person into crisis, an
Study Entry : Single Randomisation only

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above 2. Current psychiatric inpatient on a working-age adult ward 3. Diagnosis of schizophrenia-spectrum disorder or psychotic symptoms in the context of an affective disorder (International Statistical Classification of Diseases and Related Health Problems, Tenth edition [ICD-10], F2039) 4. Reports at least one current distressing positive psychotic symptom 5. Able to give informed consent to participate in trial, as assessed by consultant psychiatrist/responsible clinician 6. Willing and able to engage in psychological therapy

Exclusion criteria

Exclusion criteria: 1. Established diagnosis of learning disability, or major cognitive impairment arising from any underlying medical condition (e.g. head injury, neurological disorder) resulting in significant functional impairment 2. Unable to engage in a talking therapy in English, or to complete simple written questionnaires in English 3. Primary diagnosis of substance misuse 4. Does not report any current distressing psychotic symptoms 5. Lacks capacity to consent to participation in research trial 6. Unable to take part in individual therapy due to risk of aggression/violence 7. Mental state precludes possibility of engaging in a talking therapy, e.g. significant thought disorder

Design outcomes

Primary

MeasureTime frame
Feasibility/acceptability; Timepoint(s): At trial end (incl. recruitment rate/retention)

Secondary

MeasureTime frame
1. Pilot clinical/symptom measures; Timepoint(s): Baseline, Post-therapy, 3 month follow-up, 6 month follow-up 2. Pilot outcome data on re-admission rates; Timepoint(s): 3 and 6 month follow-up 3. Self-ratings of Psychotic Symptoms 4. Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ) 5. Depression, anxiety and stress scales (DASS-21) 6. Southampton Mindfulness Questionnaire (SMQ) 7. Questionnaire about the Process of Recovery (QPR)

Countries

United Kingdom

Contacts

Public ContactPamela Jacobsen

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 12, 2026